Protection from obesity-induced insulin resistance in mice lacking TNF- α function

Nature

Volumn 389, Issue 6651, 1997, Pages 610-614

  Uysal, K Teoman ^a   Wiesbrock, Sarah M ^a   Marino, Michael W ^b   Hotamisligil, Gökhan S ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GENE MUTATION; INSULIN RESISTANCE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ADIPOSE TISSUE; ANIMALS; FATTY ACIDS; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; HOMEOSTASIS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUTATION; OBESITY; PHOSPHORYLATION; RECEPTOR, INSULIN; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RODENTIA;

EID: 0030756346     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/39335     Document Type: Article

References (26)

1. Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 45, 3-10 (1997).
2. Carey, V. J. et al Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women - the nurses health study. Am. J. Epidemiol 145, 614-619 (1997).
3. Edelstein, S. L. et al. Predictors of progression from impaired glucose tolerance to NIDDM. Diabetes 46, 701-710 (1997).
4. Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science 259, 87-91 (1993),
5. Hofmann, C. et al Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134, 264-270 (1994).
6. Hamann, A. et. al. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44, 1266-1273 (1995).
7. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L. & Spiegelman, B. M. Increased adipose expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415 (1995).
8. Kern, P. A. et al The expresison of tumor necrosis factor in adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95, 2111-2119 (1995).
9. Saghizadeh, M., Ong, J. M., Garvey, W. T., Henry, R. R. & Kern, P. A. The expression of TNFα by human muscle: relationship to insulin resistance. J. Clin. Invest. 97, 1111-1116 (1996).
10. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L. & Spiegelman, B. M. Differential regulation of the p80 TNF receptor in human obesity and insulin resistance. Diabetes 46, 451-455 (1997).
11. Feinstein, R., Kanety, H., Papa, M. Z., Lunenfeld, B. & Karasik, A. Tumor necrosis factor-α suppresses insulin induced tyrosine phosphorylation of insulin receptor and its substrates. J. Biol. Chem. 268, 26055-26058 (1993).
12. Hotamisligil, G. S., Murray, D. L., Choy, L. N. & Spiegelman, B. M. TNF-α inhibits signaling from insulin receptor. Proc. Natl Acad. Sci. USA 91, 4854-4858 (1994).
13. Kanety, H., Feinstein, R., Papa, M. Z., Hemi, R. & Karasik, A. Tumor necrosis factor-α-induced phosphorylation of insulin receptor substrate-1 (IRS-1), J. Biol. Chem. 270, 23780-23784 (1995).
14. Kroder, G. et al Tumor necrosis factor-α- and hyperglycemia-induced insulin resistance: evidence for different mechanisms and different effects on insulin signaling. J. Clin. Invest. 97, 1471-1477 (1996).
15. Hotamisligil, G. S. et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271, 665-668 (1996).
16. Stephens, J. M. & Pekala, P. H. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-LI adipocytes by tumor necrosis factor-alpha. J. Biol. Chem. 266, 21839-21845 (1991),
17. Stephens, J. M., Lee, J. L. & Pilch, P. F. Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and glut4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem. 272, 971-976 (1997).
18. Marino, M. W. et al. Characterization of tumor necrosis factor deficient mice. Proc. Natl Acad. Sci. USA 94, 8093-8098 (1997).
19. Bruce, A. J. et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med. 2, 788-794 (1996).
20. Coleman, D. L. in The Mouse in Biomedical Research (ed. Foster, M.) 125-132 (Academic, London, 1982).
21. Olefsky, J. M. & Molina, J. M. in Diabetes Mellitus (eds Rifkin, H. & Porte, D. J.) 121-153 (Elsevier, New York, 1990).
22. Cornelius, P., Lee, M. D., Marlowe, M. & Pekala, P. H. Monokine regulation of glucose transporter mRNA in L6 myotubes, Biochem. Biophys. Res. Commun. 165, 429-436 (1989).
23. Hotamisligil, G. S., Budavari, A., Murray, D. L. & Spiegelman, B. M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-α. J. Clin. Invest. 94, 1543-1549 (1994).
24. White, M. F. & Kahn, C. R. The insulin signaling system. J. Biol. Chem. 269, 1-4 (1994).
25. Fiedorek, F. T. in Diabetes Mellitus: a Fundamental and Clinical Text (eds LeRoith, D., Taylor, S. I. & Olefsky, J. M.) 604-618 (Lippincott-Raven, Philadelphia, 1996).
26. Hotamisligil, G. S. et al Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274, 1377-1379 (1996).